Vertex Pharmaceuticals

                   

SAN DIEGO--- San Diego Science Festival Receives More than $500K in Generous Contributions from...

freshnews.com
yesterday
        

"In these difficult economic times, it's more important than ever for innovation-based companies to invest in our next generation of researchers, scientists and engineers," said Hank Nordhoff, chairman and chief executive...

add comment
                   

FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC: Half-yearly Report

finanznachrichten.de
Nov 28, 2008 2 related
        

28 November 2008 London Stock Exchange Announcement Finsbury Worldwide Pharmaceutical Trust PLC Unaudited Interim Results For the Six Months Ended 30 September 2008 INVESTMENT POLICY AND BENCHMARK Finsbury Worldwide...

add comment
                   

Quest Software Endorses European Commission Code of Conduct for ...

drugpolicycentral.com
Nov 26, 2008 3 related
        

Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous RELISTOR for Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain ... (Wed Nov 26 06:50:29 2008 PST)[$drug_related(100%),...

add comment
                   

Simulations Plus Sets Date for Fiscal Year 2008 Earnings Release ...

drugpolicycentral.com
Nov 26, 2008
        

Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous RELISTOR for Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain ... (Wed Nov 26 06:50:29 2008 PST)[$drug_related(100%),...

add comment

Finally, A Look at Schering-Plough's Pipeline (at Seeking Alpha)

yahoo.com
Nov 26, 2008 3 related
        

by: Mike Huckman November 25, 2008 | about stocks: ) raised the curtain Monday on its drug development pipeline for the first time in three years and analysts, for the most part, liked what they saw. Investors are responding to...

add comment
                   

Schering's Peacock Imitation (at Motley Fool)

yahoo.com
Nov 25, 2008 1 related
        

Schering-Plough (NYSE: SGP) has a pipeline, and it's not afraid to flaunt it. Yesterday, in fact, the company laid it all out for investors to see. But if you've been reading my articles since the company bought Organon...

add comment

Tibotec Begins European Enrollment For Phase 3 Trial Of Telaprevir In HCV Patients Who Failed...

medicalnewstoday.com
Nov 20, 2008 11 related
        

Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C virus (HCV) for whom...

add comment

Mintz Levin Represents Genelabs Technologies in $57M Deal with GlaxoSmithKline (Business Wire)

yahoo.com
Nov 18, 2008 1 related
        

BOSTON----Attorneys from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Boston and San Diego offices represented Genelabs Technologies, Inc. in a $57 million deal in which GlaxoSmithKline will acquire the Redwood City,...

add comment
                   

Credit crisis hits big Hub projects

bostonherald.com
Nov 16, 2008
        

Some towers being built but many stalled By Thomas Grillo Sunday, November 16, 2008 - Updated 3m ago Boston is in the midst of a credit crisis that has slowed most commercial real estate development to a halt. The projects...

add comment
                   

Fiscal Rx wards off bear bug

telegram.com
Nov 16, 2008
        

Health care stocks resist market’s ills Health care stocks aren’t quite as ill as the rest of the stock market in 2008. Health and biotech funds are down 25 percent in value this year, according to Lipper Inc., compared with...

add comment
1 2 next